REQUEST A DEMO
Total
USD $0.00
Search more companies

Micro Molecules Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Micro Molecules Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Micro Molecules Private Limited is an enterprise located in India, with the main office in Hyderabad. It operates in the Pharmaceutical and Medicine Manufacturing sector. It was incorporated on April 16, 2003. It currently has a total number of 9 (2025) employees. The company’s latest financial report indicates a net sales revenue drop of 41.53% in 2025. During that time, Micro Molecules Private Limited’s total assets grew by 36.11%. The net profit margin of Micro Molecules Private Limited increased by 110.67% in 2025.

Legal Address
301, Sagacity Apartments,Ameerpet, Hyderabad-16. Ameerpet, Hyderabad-16.
Hyderabad; Telangana; Postal Code: 500016

Contact Details: Purchase the Micro Molecules Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Micro Molecules Private Limited report to view the information.
Registered Capital:
Purchase the Micro Molecules Private Limited report to view the information.
Financial Auditors:
Purchase the Micro Molecules Private Limited report to view the information.
Incorporation Date:
April 16, 2003
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Whole Time Director
Company Performance
Financial values in the chart are available after Micro Molecules Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-41.53%
Total Operating Revenue
60.54%
Operating Profit
2608.38%
EBITDA
1064.38%
Net Profit/Loss for the Period
5410.8%
Total Assets
36.11%
Total Equity
259.72%
Operating Profit Margin
134.8%
Net Profit Margin
110.67%
Return on Equity (ROE)
67.49%
Quick Ratio
1.58%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?